Try
Alteogen Inc.
196170.KQSouth Korea
47 filed reports · 426 financial concepts · 0 earnings calls · 0 media appearances
Filed reports
47 reports · Dec 2014 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Annual · 11011DART | 12 | 3,683 | Dec 2014 to Dec 2025 |
| Half Year · 11012DART | 12 | 4,906 | Jun 2015 to Jun 2026 |
| Q1 · 11013DART | 12 | 4,421 | Mar 2015 to Mar 2026 |
| Q3 · 11014DART | 11 | 4,187 | Sep 2015 to Sep 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 H1 | 11012 | Jun 30, 2026 | Aug 14, 2026 | 814 | Open |
| FY2026 Q1 | 11013 | Mar 31, 2026 | May 15, 2026 | 691 | Open |
| FY2025 | 11011 | Dec 31, 2025 | Mar 23, 2026 | 824 | Open |
| FY2025 Q3 | 11014 | Sep 30, 2025 | Nov 14, 2025 | 508 | Open |
| FY2025 H1 | 11012 | Jun 30, 2025 | Aug 13, 2025 | 389 | Open |
| FY2025 Q1 | 11013 | Mar 31, 2025 | May 13, 2025 | 325 | Open |
| FY2024 | 11011 | Dec 31, 2024 | Mar 21, 2025 | 340 | Open |
| FY2024 Q3 | 11014 | Sep 30, 2024 | Nov 14, 2024 | 394 | Open |
| FY2024 H1 | 11012 | Jun 30, 2024 | Aug 14, 2024 | 386 | Open |
| FY2024 Q1 | 11013 | Mar 31, 2024 | May 16, 2024 | 314 | Open |
| FY2023 | 11011 | Dec 31, 2023 | Mar 18, 2024 | 547 | Open |
| FY2023 Q3 | 11014 | Sep 30, 2023 | Nov 14, 2023 | 382 | Open |
Financial data
426 concepts · 17,197 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
IFRS404 concepts · 16,954 facts · Dec 2012 to Jun 2026
- Stockholders Equity180 · Dec 2012 to Jun 2026
- Cash and Equivalents174 · Dec 2012 to Jun 2026
- Cost of Revenue174 · Dec 2012 to Jun 2026
- EPS (Basic)174 · Dec 2012 to Jun 2026
- EPS (Diluted)174 · Dec 2012 to Jun 2026
- Finance Income174 · Dec 2012 to Jun 2026
- Gross Profit174 · Dec 2012 to Jun 2026
- Income Tax Expense (Benefit)174 · Dec 2012 to Jun 2026
- Interest Expense174 · Dec 2012 to Jun 2026
- Issued Share Capital174 · Dec 2012 to Jun 2026
- Net Income174 · Dec 2012 to Jun 2026
- Operating Income174 · Dec 2012 to Jun 2026
- Other Current Financial Liabilities174 · Dec 2012 to Jun 2026
- Other gains174 · Dec 2012 to Jun 2026
- Other losses174 · Dec 2012 to Jun 2026
- Other Noncurrent Financial Liabilities174 · Dec 2012 to Jun 2026
- Pretax Income174 · Dec 2012 to Jun 2026
- Property, Plant & Equipment, Net174 · Dec 2012 to Jun 2026
- Retained Earnings (Accumulated Deficit)174 · Dec 2012 to Jun 2026
- Revenue174 · Dec 2012 to Jun 2026
- SG&A Expense174 · Dec 2012 to Jun 2026
- Total Assets174 · Dec 2012 to Jun 2026
- Total Comprehensive Income174 · Dec 2012 to Jun 2026
- Total Current Assets174 · Dec 2012 to Jun 2026
Segment22 concepts · 243 facts · Dec 2024 to Jun 2026
- Number of share options exercisable in share-based payment arrangement26 · Dec 2024 to Jun 2026
- Revenue20 · Dec 2024 to Jun 2026
- Revenue from rendering of services20 · Dec 2024 to Jun 2026
- Revenue from sale of goods product20 · Dec 2024 to Jun 2026
- Weighted average exercise price of share options exercisable in share-based payment arrangement20 · Dec 2024 to Jun 2026
- Number of share options granted in share-based payment arrangement18 · Dec 2024 to Jun 2026
- Number of share options expired in share-based payment arrangement17 · Dec 2024 to Jun 2026
- Revenue from sale of goods merchandise16 · Dec 2024 to Jun 2026
- Weighted average exercise price of share options granted in share-based payment arrangement12 · Dec 2024 to Jun 2026
- Issued amount, convertible preferred stock11 · Dec 2024 to Jun 2026
- Weighted average exercise price of share options expired in share-based payment arrangement10 · Dec 2024 to Jun 2026
- Exercise price of outstanding share options8 · Dec 2025 to Jun 2026
- Number of share options outstanding in share-based payment arrangement8 · Mar 2025 to Jun 2026
- Increase (decrease) in weighted average exercise price of share options through merger7 · Mar 2025 to Jun 2026
- Capital commitments6 · Mar 2025 to Jun 2026
- Increase (decrease) in number of share options through merger5 · Mar 2025 to Jun 2026
- Expected dividend as percentage, share options granted4 · Mar 2026 to Jun 2026
- Number of share options exercised in share-based payment arrangement4 · Dec 2024 to Jun 2026
- Weighted average exercise price of share options exercised in share-based payment arrangement4 · Dec 2024 to Jun 2026
- Option life, share options granted3 · Dec 2025 to Jun 2026
- Issued amount, onvertible redeemable preferred stock2 · Dec 2024 to Dec 2025
- Weighted average exercise price of share options outstanding in share-based payment arrangement2 · Mar 2025 to Jun 2025
Segments
243 factsFigures broken down by business line, region, product or another axis the company reports on.
Segments11 members · 167 facts
- AlteogenBiologicsIncMemberOfSegmentsMemberOfDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsTableOfMember54 · Dec 2024 to Jun 2026
- AlteogenIncMemberOfSegmentsMemberOfDisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsTableOfMember51 · Dec 2024 to Jun 2026
- AlteogenBiologicsIncMemberOfReportableSegmentsMemberOfDisclosureOfImpairmentOnDevelopmentExpenseTableOfMember15 · Dec 2024 to Jun 2026
- AlteogenBiologicsIncMemberOfSegmentsMemberOfDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTableOfMember12 · Dec 2025 to Jun 2026
- AlteogenIncMemberOfSegmentsMemberOfDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTableOfMember12 · Dec 2025 to Jun 2026
- AlteogenIncMemberOfSegmentsMemberOfDisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodTableOfMember5 · Dec 2025 to Jun 2026
- AlteogenBiologicsIncMemberOfSegmentsMemberOfDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTableOfMember4 · Dec 2025 to Jun 2026
- AlteogenBiologicsIncMemberOfSegmentsMemberOfDisclosureOfShareBasedPaymentOfTheMergedCompanyTableOfMember4 · Mar 2025 to Jun 2025
- AlteogenHealthcareIncMemberOfSegmentsMemberOfIssuedAmountOfConvertibleRedeemablePreferredStockAndConvertiblePreferredStockTableOfMember4 · Dec 2024 to Dec 2025
- AlteogenIncMemberOfSegmentsMemberOfDisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTableOfMember4 · Dec 2025 to Jun 2026
- AlteogenBiologicsIncMemberOfSegmentsMemberOfDisclosureOfIndirectMeasurementOfFairValueOfGoodsOrServicesReceivedShareOptionsGrantedDuringPeriodTableOfMember2 · Mar 2026 to Jun 2026
Geographical areas2 members · 76 facts
- CountryOfDomicileMember38 · Dec 2024 to Jun 2026
- ForeignCountriesMember38 · Dec 2024 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.